A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Clinical trial NCT04440943 · COMPLETED

Trial details

NCT number: NCT04440943
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Breast Cancer Gastric Cancer Renal Cell Carcinoma Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Cancer Cholangiocarcinoma Bladder Urothelial Carcinoma MSI-H Colorectal Cancer Esophageal Cancer Hepatic Cancer

Start date: 2020-08-04
Primary completion: 2023-04-06
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.